Text Size
95 studies found for:    Open Studies | "Nasopharyngeal Neoplasms"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Cisplatin;   Drug: Paclitaxel;   Radiation: IMRT
2 Recruiting Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: ABX + DDP
3 Recruiting A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Conditions: Nasopharyngeal Neoplasms;   Salivary Gland Diseases;   Bone Marrow Diseases;   Mucositis
Interventions: Drug: Amifostine every-other-day regimen;   Drug: Amifostine everyday regimen
4 Recruiting GP Versus PF in the Treatment of Advanced Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: gemcitabine and cisplatin;   Drug: 5-Fluorouracil and cisplatin
5 Unknown † Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Oxaliplatin
6 Not yet recruiting Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Condition: Nasopharyngeal Neoplasms
Interventions: Procedure: Conventional Radiotherapy;   Procedure: Accelerated Radiotherapy;   Drug: Cisplatin;   Drug: 5-fluorouracil;   Drug: Capecitabine
7 Unknown † Intensity Modulated Radiation Therapy for Head and Neck Cancer
Condition: Nasopharyngeal Neoplasms
Interventions: Procedure: intensity modulated radiation therapy;   Drug: cisplatinium and fluorouracil - standard treatment
8 Recruiting A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Erlotinib;   Drug: Sulindac;   Drug: Placebo A;   Drug: Placebo B
9 Recruiting A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors
Conditions: Nasopharyngeal Carcinoma;   Hepatocellular Carcinoma;   Breast Carcinoma
Intervention: Biological: tumor infiltrating lymphocytes, IL-2
10 Not yet recruiting Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Inductive chemotherapy + concurrent cisplatin and IMRT;   Drug: Inductive chemotherapy + IMRT
11 Recruiting Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy
Conditions: Nasopharyngeal Carcinoma;   Radiotherapy
Interventions: Behavioral: Traditional rehabilitation (TR);   Behavioral: Transcutaneous electrical stimulation (ES)
12 Recruiting A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: nedaplatin and docetaxel;   Drug: cisplatin and docetaxel
13 Unknown † Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: 5-fluorouracil (5-FU)
14 Recruiting Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Conditions: Nasopharyngeal Cancer;   Epstein-Barr Virus Infections
Intervention: Biological: Recombinant Epstein-Barr Virus (EBV) Vaccine
15 Unknown † Cisplatin and Radiation Therapy With or Without Gemcitabine Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced Nasopharyngeal Cancer
Condition: Head and Neck Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Radiation: intensity-modulated radiation therapy
16 Recruiting New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer
Condition: Advanced Nasopharyngeal Carcinoma
Intervention: Drug: Chemotherapy
17 Recruiting Environmental and Genetic Determinants of Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Carcinoma
Intervention:
18 Unknown † Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Intervention: Drug: Docetaxel, Cisplatin
19 Unknown † Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: docetaxel, cisplatin, fluorouracil
20 Recruiting Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Colon Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Rectal Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer;   Tongue Cancer
Interventions: Biological: cetuximab;   Drug: lenalidomide;   Other: laboratory biomarker analysis
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years